輔酶一(NAD)與老年化疾病課件_第1頁(yè)
輔酶一(NAD)與老年化疾病課件_第2頁(yè)
輔酶一(NAD)與老年化疾病課件_第3頁(yè)
輔酶一(NAD)與老年化疾病課件_第4頁(yè)
輔酶一(NAD)與老年化疾病課件_第5頁(yè)
已閱讀5頁(yè)，還剩31頁(yè)未讀， 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明：本文檔由用戶(hù)提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Age-relateddiseasesandcancer

Age-relateddiseasesCOENZYMEI精品1Age-relateddiseasesandcanceCONTENTSA.NADbiosyntheticpathwaysandmetabolismB.NADconsumingenzymesinhealthanddiseaseC.Age-relateddiseasesandcancerD.MechanismsofNADPrecursorsinhumansandanimalmodelsE.NADandthehallmarksofaging精品2CONTENTSA.NADbiosyntheticpaA.NADbiosyntheticpathwaysandmetabolism精品3A.NADbiosyntheticpathwaysanNADbiosyntheticpathwaysandmetabolismEricVerdin.(2015).SpecialSection350（6265）:1208-1213.NAD

biosyntheticpathwaysandmetabolismindifferentcellularcompartments.精品4NADbiosyntheticpathwaysandB.NADconsumingenzymesinhealthanddisease精品5B.NADconsumingenzymesinheaNADconsumingenzymesinhealthanddiseaseEF.Fang,.(2017).NAD+:akeymetabolicregulatorwithgreattherapeuticpotential:1120-1143.NADavailabilitycaninfluencetheactivityofthreegroupsofmasterregulatorenzymesthesirtuins,thePARPsandcyclicADP-ribosesynthases.EachgroupofenzymesregulatemanybiologicalprocessesandcanthuscouplechangesinNADlevelswithawiderangeofphysiologicalresponses.精品6NADconsumingenzymesinhealtC.Age-relateddiseasesandcancer精品7C.Age-relateddiseasesandcan1980s1930s……Age-relateddiseasesandcancercouldbetheconsequenceofadeclineinNAD+concentrationsAmandaGarrido(2017).Trendincancer181:181-199.Age-relateddiseasesandcancerMetabolicsyndromeincludingcardiovasculardisorders,type2diabetesandobesity,Neurodegenerativediseases

suchasAlzheimerandParkinsondiseases,arthritis,andosteoporosis,andcancer

aresomeofthediseasesthatcommonlyaffecthumanhealthduringaging.精品81980s1930s……Age-relateddiseasD.BenefitsandmechanismsofNADprecursorsinhumansandanimalmodels精品9D.BenefitsandmechanismsofNBenefitsandmechanismsofNADprecursorsinhumansandanimalmodelsGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品10BenefitsandmechanismsofNADBenefitsandmechanismsofNADprecursorsinhumansandanimalmodelsGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品11BenefitsandmechanismsofNADBenefitsandmechanismsofNADprecursorsinhumansandanimalmodelsGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品12BenefitsandmechanismsofNADE.NADandthehallmarksofaging精品13E.NADandthehallmarksofagiNADandthehallmarksofagingGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品14NADandthehallmarksofagingNADandthehallmarksofagingGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品15NADandthehallmarksofagingNADandthehallmarksofagingGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品16NADandthehallmarksofagingNADandthehallmarksofagingGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品17NADandthehallmarksofagingTheEnd精品18TheEnd精品18Age-relateddiseasesandcancer

Age-relateddiseasesCOENZYMEI精品19Age-relateddiseasesandcanceCONTENTSA.NADbiosyntheticpathwaysandmetabolismB.NADconsumingenzymesinhealthanddiseaseC.Age-relateddiseasesandcancerD.MechanismsofNADPrecursorsinhumansandanimalmodelsE.NADandthehallmarksofaging精品20CONTENTSA.NADbiosyntheticpaA.NADbiosyntheticpathwaysandmetabolism精品21A.NADbiosyntheticpathwaysanNADbiosyntheticpathwaysandmetabolismEricVerdin.(2015).SpecialSection350（6265）:1208-1213.NAD

biosyntheticpathwaysandmetabolismindifferentcellularcompartments.精品22NADbiosyntheticpathwaysandB.NADconsumingenzymesinhealthanddisease精品23B.NADconsumingenzymesinheaNADconsumingenzymesinhealthanddiseaseEF.Fang,.(2017).NAD+:akeymetabolicregulatorwithgreattherapeuticpotential:1120-1143.NADavailabilitycaninfluencetheactivityofthreegroupsofmasterregulatorenzymesthesirtuins,thePARPsandcyclicADP-ribosesynthases.EachgroupofenzymesregulatemanybiologicalprocessesandcanthuscouplechangesinNADlevelswithawiderangeofphysiologicalresponses.精品24NADconsumingenzymesinhealtC.Age-relateddiseasesandcancer精品25C.Age-relateddiseasesandcan1980s1930s……Age-relateddiseasesandcancercouldbetheconsequenceofadeclineinNAD+concentrationsAmandaGarrido(2017).Trendincancer181:181-199.Age-relateddiseasesandcancerMetabolicsyndromeincludingcardiovasculardisorders,type2diabetesandobesity,Neurodegenerativediseases

suchasAlzheimerandParkinsondiseases,arthritis,andosteoporosis,andcancer

aresomeofthediseasesthatcommonlyaffecthumanhealthduringaging.精品261980s1930s……Age-relateddiseasD.BenefitsandmechanismsofNADprecursorsinhumansandanimalmodels精品27D.BenefitsandmechanismsofNBenefitsandmechanismsofNADprecursorsinhumansandanimalmodelsGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品28BenefitsandmechanismsofNADBenefitsandmechanismsofNADprecursorsinhumansandanimalmodelsGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品29BenefitsandmechanismsofNADBenefitsandmechanismsofNADprecursorsinhumansandanimalmodelsGSultani.(2017).TrendsinMolecularMedicine23（10）:900-918精品30BenefitsandmechanismsofNADE.NADandthehallmar

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽，若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間，僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理，對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請(qǐng)與我們聯(lián)系，我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論